• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    Cara Therapeutics Inc. (CARA)

    -NasdaqGM
    9.78 0.02(0.20%) Dec 24, 12:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 11,964   1,190   -  
    Cost of Revenue -   -   -  
    Gross Profit 11,964   1,190   -  
    Operating Expenses
    Research Development8,685  4,597  7,159  
    Selling General and Administrative3,516  2,829  2,407  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (237) (6,236) (9,566)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -  (180)
    Earnings Before Interest And Taxes(237)(6,236)(9,746)
    Interest Expense3,756  66  95  
    Income Before Tax(3,993)(6,302)(9,841)
    Income Tax Expense(30)(31)(35)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(3,963)(6,271)(9,806)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (3,963) (6,271) (9,806)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (3,963) (6,271) (9,806)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.